🔎 Trials Near Me

Hjem › Alzheimers sygdom › Oklahoma

Alzheimers sygdom kliniske forsøg i Oklahoma

6 studier for Alzheimers sygdom søger deltagere på steder i Oklahoma.

Byer i Oklahoma

Officiel studietekst (engelsk)

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1640, Tulsa
RekruttererFase 3
Alder 55 til 90 · Alle køn · Opdateret 28. sep. 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • The Rivus Wellness & Research Institute, Oklahoma City
RekruttererFase 3
Alder 55 til 90 · Alle køn · Opdateret 22. sep. 2026 · NCT06585787

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • Central States Research, Tulsa
RekruttererFase 3
Alder 55 til 90 · Alle køn · Opdateret 16. sep. 2026 · NCT07011732

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Local Institution - 0089, Ardmore
RekruttererFase 2
Alder 55 til 90 · Alle køn · Opdateret 1. sep. 2026 · NCT06808984

Using Light Therapy for Mild Cognitive Impairment

  • University of Oklahoma Health Campus, Oklahoma City
Rekrutterer
Alder 55 til 95 · Alle køn · Opdateret 16. jun. 2026 · NCT07651787

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Oklahoma City
RekruttererFase 2
Alder 50 til 85 · Alle køn · Opdateret 2. feb. 2026 · NCT07105709

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.